NAMI
MYGN icon

Nomura Asset Management International’s Myriad Genetics MYGN Stock Holding History

Nomura Asset Management International’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Hold
50,000
– – ﹤0.01% 1297
2026
Q1 		$225K Hold
50,000
– – ﹤0.01% 1217
2025
Q4 		$308K Buy
+50,000
New +$363K ﹤0.01% 1204

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nomura Asset Management International's MYGN Position: Q2 2026 in Review

Nomura Asset Management International held its Myriad Genetics (MYGN) position steady in Q2 2026 at 50,000 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Nomura Asset Management International first reported a position in MYGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $308K in Q4 2025. 195 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Nomura Asset Management International held 50,000 shares of Myriad Genetics worth $286K as of Q2 2026.
  • Nomura Asset Management International left its Myriad Genetics share count unchanged in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1297 holding.
  • Nomura Asset Management International first reported a position in Myriad Genetics in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Myriad Genetics position peaked at $308K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.